引用本文
  •    [点击复制]
  •    [点击复制]
PDF HTML全文阅读
本文已被:浏览 75次   下载 64 本文二维码信息
码上扫一扫!
T2期胆囊癌肝切除必要性的Meta分析
孙喆,徐新生,赵宏志
0
天津市中西医结合医院天津300100
摘要:
目的:通过Meta分析研究肝切除术对于T2期胆囊癌患者预后的影响。方法:检索Pubmed、Embase、Web of Science、Cochrane Library、中国知网、万方、维普网站。英文检索词汇包括:gallbladder carcinoma, surgery, cholecystectomy, radical cholecystectomy, hepatectomy, liver resection。中文检索词汇包括:胆囊癌、手术、胆囊切除术、根治性胆囊切除、肝切除。比较两组患者的总体生存率、无病生存率、术后并发症和术后30 d死亡率。使用RevMan 5.4统计软件对数据进行Meta分析。结果:共有20个研究包含3222例患者被纳入,其中1959例患者进行了肝切除,1263例未进行肝切除。Meta分析结果显示,肝切除组与非肝切除组患者术后总生存率[风险比(RR)=0.93,95%CI:0.77~1.12,P =0.44],术后无病生存率(RR=1.11,95%CI:0.84~1.47,P =0.45),术后并发症发生率(RR=2.00,95%CI:0.71~5.62,P =0.19)及术后30 d内死亡率(RR=0.90,95%CI:0.10~8.02,P =0.92)均无显著统计学差异。结论:对于T2期胆囊癌的患者,并不能从肝切除术中获益。
关键词:  胆囊癌  胆囊切除  肝切除
DOI:10.3969/j.issn.1007-6948.2024.06.022
投稿时间:2024-04-09
基金项目:天津市卫健委中西医结合课题(2023095)
Meta-analysis on the necessity of hepatectomy for T2 stage gallbladder cancer
SUN Zhe,XU Xin-sheng,ZHAO Hong-zhi
Tianjin Hospital of Integrated Traditional Chinese and Western Medicine , Tianjin300100, China
Abstract:
Objective To investigate the impact of hepatectomy on the prognosis of patients with T2 stage gallbladder cancer through Meta-analysis. Methods Databases including PubMed, Embase, Web of Science, Cochrane Library, CNKI, Wanfang Database, and VIP Database were searched. The search terms included: gallbladder carcinoma, surgery, cholecystectomy, radical cholecystectomy, hepatectomy, liver resection. Comparative analysis was conducted on indicators such as overall survival, disease-free survival, postoperative complication rate, and mortality within 30 days after surgery between the hepatectomy group and the non-hepatectomy group. Meta-analysis was performed using RevMan 5.4 software. Results A total of 20 studies involving 3222 patients were included, with 1959 patients in the hepatectomy group and 1263 patients in the non-hepatectomy group. Meta-analysis results showed no significant statistical differences in postoperative overall survival rate (RR=0.93, 95%CI: 0.77-1.12, P =0.44), postoperative disease-free survival rate (RR=1.11, 95%CI: 0.84-1.47, P =0.45), postoperative complication rate (RR=2.00,95%CI:0.71-5.62,P =0.19, and mortality within 30 days after surgery (RR=0.90, 95%CI: 0.10-8.02, P =0.92) between the hepatectomy group and the non-hepatectomy group. Conclusion Hepatectomy does not benefit patients with T2 stage gallbladder cancer.
Key words:  Gall bladder cancer  cholecystectomy  hepatectomy

用微信扫一扫

用微信扫一扫